Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.